Exploring COVID-19 Vaccine Hesitancy Amongst Black Americans: Contributing Factors and Motivators.


Journal

American journal of health promotion : AJHP
ISSN: 2168-6602
Titre abrégé: Am J Health Promot
Pays: United States
ID NLM: 8701680

Informations de publication

Date de publication:
11 2022
Historique:
pubmed: 5 5 2022
medline: 1 11 2022
entrez: 4 5 2022
Statut: ppublish

Résumé

To determine reasons for hesitancy towards COVID-19 vaccination and motivators to increase COVID-19 vaccine uptake among Black Americans. Mixed-methods. Individual interviews in March-April 2021. Black adults (20-79 years) who attended a church in Boston, MA and identified as "vaccine hesitant" (n = 18). Individual in-depth Zoom interviews to elicit participant views on vaccines in general, specific reasons for COVID-19 vaccine hesitancy, and trusted sources of information. Participants were also asked about possible motivators that could increase COVID-19 vaccine uptake. Transcripts were de-identified and analyzed for major themes using an inductive approach. Analysis included 18 complete interviews. Lack of trust in the government, healthcare, or pharmaceutical companies (n = 18), rushed development (n = 14), fear of side effects (n = 12), history of medical mistreatment (n = 12), and a perception of low risk of disease (n = 9) were the top-cited reasons for COVID-19 vaccine hesitancy. Motivators likely to increase COVID-19 vaccine uptake included more data (n = 17), friends and family getting vaccinated (not celebrities) (n = 11), and increased opportunities that come along with being vaccinated (n = 8). There were many reasons for COVID-19 vaccine hesitancy, as reported by participants who were all Black Americans in the Boston area. The public health challenge of increasing vaccine uptake in the Black community is nuanced and intervention efforts may be more successful if delivered by trusted members of the community and tailored to the needs of individuals.

Identifiants

pubmed: 35506153
doi: 10.1177/08901171221099270
pmc: PMC9618913
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

1304-1315

Références

Ann Epidemiol. 2020 Jul;47:37-44
pubmed: 32419766
PRiMER. 2017 Aug 31;1:15
pubmed: 32944701
Soc Sci Med. 2019 Jan;221:87-94
pubmed: 30576982
Expert Rev Vaccines. 2020 Oct;19(10):919-936
pubmed: 32940090
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Brain Behav Immun Health. 2020 Dec;9:100159
pubmed: 33052327
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
Soc Sci Med. 2017 Nov;193:70-79
pubmed: 29028558
Vaccine. 2019 Feb 21;37(9):1168-1173
pubmed: 30709722
Vaccine. 2021 Jun 2;39(24):3250-3258
pubmed: 33966909
J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324
pubmed: 32238757
Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609
pubmed: 29617183
Soc Sci Med. 2021 Mar;272:113638
pubmed: 33414032
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
J Gen Intern Med. 2021 Nov;36(11):3629-3631
pubmed: 34021446
Fam Med. 2020 Oct;52(9):626-630
pubmed: 33030717
Am J Public Health. 1997 Nov;87(11):1773-8
pubmed: 9366634
BMC Public Health. 2021 Apr 28;21(1):818
pubmed: 33910558
PLoS Curr. 2016 Dec 29;8:
pubmed: 28239512
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694

Auteurs

Sayuri Sekimitsu (S)

12261Tufts University School of Medicine, Boston, MA, USA.

Jessica Simon (J)

12261Tufts University School of Medicine, Boston, MA, USA.

Mika Matsuuchi Lindsley (MM)

12261Tufts University School of Medicine, Boston, MA, USA.

Melissa Jones (M)

1812Harvard University, Cambridge, MA, USA.

Umin Jalloh (U)

43982Rutgers Robert Wood Johnson Medical School New Brunswick, New Brunswick, NJ, USA.

Titilayo Mabogunje (T)

12261Tufts University School of Medicine, Boston, MA, USA.

Jordyn Kerr (J)

7254Union College, Schenectady, NY, USA.

Mikayla Willingham (M)

St. John University College of Professional Studies, Queens, NY, USA.

Sula Bahiyyih Ndousse-Fetter (SB)

1811Harvard Medical School, Boston, MA, USA.

Gloria White-Hammond (G)

80331Harvard Divinity School, Cambridge, MA, USA.

Wayne Altman (W)

Department of Family Medicine, 1810Tufts University School of Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH